COMMON STI571: A COST-EFFECTIVE CHOICE?

The arrival of generic imatinib represents a substantial opportunity for patients battling chronic myeloid leukemia and other conditions. Original brand-name imatinib, branded as Gleevec, carries a high price tag, frequently making it accessibility for some individuals. Common versions, usually m